Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before. Earlier this week, Life Biosciences, a biotech company focused on reversing age-related ...

Plus: SpaceX has officially delivered the largest IPO in history. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Belden gains Wi-Fi and enterprise switching products in the deal and adds to its existing portfolio of passive networking infrastructure, OT wireless, and industrial switching gear. Belden (NYSE: BDC) ...

ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC) (“Belden” or the “Company”), a leading global supplier of specialty networking solutions, today announced it has entered into a definitive agreement ...

Shares of Vistance Networks (VISN) continue to make progress, with many events taking place since I called the sum of the parts analysis starting to look interesting in the middle of March. Following ...

Belden looks to have pipped Extreme Networks to the post in its bid to acquire Ruckus Networks. Reports in January suggested Extreme was looking to splash around $1 billion on Ruckus, but Belden ...

“Today, we announced an important step in our solutions journey, an agreement to acquire Ruckus Networks, a market-leading provider of Wi-Fi and enterprise switching solutions.” (President, CEO & ...

Vistance Networks (NASDAQ: VISN), a global provider of intelligent network solutions, announced today it has entered into a definitive agreement to sell its RUCKUS Networks business to Belden Inc.

GREENVILLE, N.C. (WITN) - ECU Health confirmed Wednesday they are now out of network with UnitedHealthcare. ECU Health’s website says Wednesday marked the deadline where physicians could be out of ...

HOST-Factor levels indicate Gem-PLDR induces a supportive-to-restrictive CAFu-generated ECM transition. (A) Graph of HOST-Factor values calculated from the 5 phenotypic assays ( Figures 3–5 ). Zero ...

The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever, and general malaise. Those symptoms, which typically resolve within days, are the natural ...